Andrzej Stankiewicz Selected Research

Andrzej Stankiewicz Research Topics

6	Glaucoma 11/2010 - 01/2002
6	Cataract (Cataracts) 03/2010 - 01/2003
4	Macular Edema 04/2012 - 01/2003
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 02/2011 - 01/2006
3	Macular Degeneration (Age-Related Maculopathy) 09/2011 - 01/2002
3	Hemorrhage 01/2008 - 01/2002
2	Capsule Opacification 03/2010 - 01/2009
2	Gliosis 01/2010 - 01/2010
2	Choroidal Neovascularization 01/2008 - 01/2005
2	Hypertension (High Blood Pressure) 01/2008 - 01/2004
1	Reperfusion Injury 11/2010
1	Pathologic Processes 01/2010
1	Stroke (Strokes) 01/2008
1	Epiretinal Membrane (Epiretinal Membranes) 01/2008
1	Atrophy 01/2008
1	Blister (Bulla) 01/2008
1	Coronary Disease (Coronary Heart Disease) 01/2008
1	Fibrosis (Cirrhosis) 01/2008
1	Heart Failure 01/2008
1	Hypercholesterolemia 01/2008
1	Hypotension (Low Blood Pressure) 01/2008
1	Migraine Disorders (Migraine) 01/2008
1	Muscle Hypotonia (Hypotonia) 01/2008
1	Myopia 01/2008
1	Ocular Hypertension (Glaucoma, Suspect) 01/2008
1	Type 2 Diabetes Mellitus (MODY) 03/2005
1	Endophthalmitis (Ophthalmia) 01/2005
1	Inflammation (Inflammations) 01/2005
1	Wounds and Injuries (Trauma) 01/2005
1	Rupture 01/2004
1	Metabolic Diseases (Metabolic Disease) 01/2004
1	Collagen Diseases (Collagen Disease) 01/2004
1	Bacterial Infections (Bacterial Infection) 01/2003
1	Bacterial Conjunctivitis 01/2003
1	Hyperthyroidism 01/2003
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2003
1	Retinal Detachment (Retinal Detachments) 01/2002
1	Prolapse 01/2002
1	Lacrimal Apparatus Diseases (Epiphora) 01/2002
1	Choroidal Effusions 01/2002

5	Retinaldehyde (Retinal)IBA 04/2012 - 01/2002
2	Ranibizumab (Lucentis)FDA Link 09/2011 - 01/2008
2	dorzolamide (Trusopt)FDA LinkGeneric 02/2011 - 10/2010
2	Bimatoprost (Lumigan)FDA Link 02/2011 - 10/2010
2	Capsules (Microcapsules)IBA 01/2009 - 01/2004
2	AntimetabolitesIBA 01/2008 - 01/2006
1	Bevacizumab (Avastin)FDA Link 04/2012
1	Matrix Metalloproteinases (MMPs)IBA 11/2010
1	Endothelins (Endothelin)IBA 11/2010
1	SolutionsIBA 03/2010
1	CytokinesIBA 01/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2010
1	CollagenIBA 01/2010
1	VitaminsIBA 01/2008
1	Verteporfin (Visudyne)FDA Link 01/2008
1	hydroxide ionIBA 01/2008
1	CholesterolIBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	Angiogenesis InhibitorsIBA 01/2008
1	Gliclazide (Diamicron)IBA 03/2005
1	Pioglitazone (Actos)FDA Link 03/2005
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2005
1	Timolol (Blocadren)FDA LinkGeneric 01/2004
1	ProstaglandinsIBA 01/2004
1	Ophthalmic Solutions (Eye Drops)IBA 01/2003
1	vascular factorIBA 01/2003
1	ArgonIBA 01/2003
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2003
1	Pharmaceutical PreparationsIBA 01/2003
1	IodineIBA 01/2003
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 01/2002

6	Vitrectomy 04/2012 - 01/2002
6	Therapeutics 04/2012 - 01/2004
4	Phacoemulsification 03/2010 - 01/2004
4	Traction 01/2010 - 01/2003
2	Intravitreal Injections 09/2011 - 01/2008
2	Photochemotherapy (Photodynamic Therapy) 01/2008 - 01/2005
2	Lasers (Laser) 01/2003 - 01/2003
1	Injections 09/2011
1	Multifocal Intraocular Lenses 01/2006
1	Refractive Surgical Procedures 01/2006
1	Glycemic Control 03/2005
1	Vitreoretinal Surgery 01/2005
1	Drug Therapy (Chemotherapy) 01/2005
1	Light Coagulation 01/2005
1	Intraoperative Period 01/2004
1	Filtering Surgery 01/2002
1	Penetrating Keratoplasty 01/2002
1	Transplantation 01/2002
1	Operative Surgical Procedures 01/2002
1	Cataract Extraction 01/2002